Fig. 5From: Pilot study of repeated blood-brain barrier disruption in patients with mild Alzheimer’s disease with an implantable ultrasound deviceFDG PET changes in the target ROI (ROI1) referenced to the whole cerebellum. Overall, a blunting or plateau of decline was observed in the target region referenced to the whole cerebellum after 4 monthsBack to article page